Organ specific responses to first-line lenvatinib plus anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma: a retrospective analysis

• Main Authors: Cheng Huang (Author), Xiao-Dong Zhu (Author), Ying-Hao Shen (Author), Dong Wu (Author), Yuan Ji (Author), Ning-Ling Ge (Author), Ling-Li Chen (Author), Chang-Jun Tan (Author), Jian Zhou (Author), Jia Fan (Author), Hui-Chuan Sun (Author)
• Formato: Livro
• Publicado em: BMC, 2021-03-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Background We evaluated organ-specific response rates (OSRRs) to first-line lenvatinib plus anti-PD-1 antibodies in patients with advanced hepatocellular carcinoma (HCC). Methods This retrospective analysis included Chinese patients with unresectable/advanced HCC who received first-line len...